Clinical Pharmacology and Translational Aspects of Bispecific Antibodies-Reference-Cited by-同舟云学术

Clinical Pharmacology and Translational Aspects of Bispecific Antibodies

Published:2017-03-15 Issue:3 Volume:10 Page:147-162
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical And Translational Science

Author:

Trivedi A¹,Stienen S²,Zhu M¹,Li H¹,Yuraszeck T¹,Gibbs J¹³,Heath T¹,Loberg R¹,Kasichayanula S¹⁴

Affiliation:

1. Amgen Inc.; Thousand Oaks California USA

2. Amgen Research (Munich); Munich Germany

3. Current address: AbbVie Inc.; North Chicago Illinois USA

4. Current Address: AbbVie Inc.; South San Francisco California USA

Funder

Amgen

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cts.12459/fullpdf

Reference85 articles.

1. U.S. Department of Health and Human Services FaDA Center for Drug Evaluation and Research (CDER) Codevelopment of Two or More New Investigational Drugs for Use in Combination http://wwwfdagov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/defaulthtm 2013

2. A novel bispecific antibody targeting EGFR and cMet is effective against EGFR inhibitor-resistant lung tumors;Moores;Cancer Res.,2016

3. The application of mathematical modelling to the design of bispecific monoclonal antibodies;Steeg;mAbs.,2016

4. A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications;Byrne;Trends Biotechnol.,2013

5. Engineered proteins with desired specificity: DARPins, other alternative scaffolds and bispecific IgGs;Jost;Current Opin. Struct. Biol.,2014

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. General Quasi-Equilibrium Multivalent Binding Model to Study Diverse and Complex Drug-Receptor Interactions of Biologics;2024-01-25

2. Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overview;Frontiers in Immunology;2023-12-04

3. Research and development of antibody-based novel anti-cancer drugs: An overview;Intelligent Pharmacy;2023-09

4. Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases;Clinical Cancer Research;2023-05-18

5. Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes;Cancers;2023-04-20